120 related articles for article (PubMed ID: 21533856)
1. Diagnostic features of mild cellulitis phlegmon in patients with rheumatoid arthritis treated with tocilizumab: a report of two cases.
Hirao M; Nampei A; Shi K; Yoshikawa H; Nishimoto N; Hashimoto J
Mod Rheumatol; 2011 Dec; 21(6):673-7. PubMed ID: 21533856
[TBL] [Abstract][Full Text] [Related]
2. Analysis of perioperative clinical features and complications after orthopaedic surgery in rheumatoid arthritis patients treated with tocilizumab in a real-world setting: results from the multicentre TOcilizumab in Perioperative Period (TOPP) study.
Momohara S; Hashimoto J; Tsuboi H; Miyahara H; Nakagawa N; Kaneko A; Kondo N; Matsuno H; Wada T; Nonaka T; Kanbe K; Takagi H; Murasawa A; Matsubara T; Suguro T
Mod Rheumatol; 2013 May; 23(3):440-9. PubMed ID: 22684398
[TBL] [Abstract][Full Text] [Related]
3. Leucine-rich α2 -glycoprotein as a potential biomarker for joint inflammation during anti-interleukin-6 biologic therapy in rheumatoid arthritis.
Fujimoto M; Serada S; Suzuki K; Nishikawa A; Ogata A; Nanki T; Hattori K; Kohsaka H; Miyasaka N; Takeuchi T; Naka T
Arthritis Rheumatol; 2015 May; 67(8):2056-60. PubMed ID: 25917892
[TBL] [Abstract][Full Text] [Related]
4. [Immunosuppression may mask severe infection. Septic arthritis in tocilizumab treatment yielded only modest acute-phase reaction].
Ljung L; Smeds J; Persson G; Jirlén L; Toolanen G
Lakartidningen; 2012 Sep 19-26; 109(38):1678-9. PubMed ID: 23094399
[No Abstract] [Full Text] [Related]
5. Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study.
Yazici Y; Curtis JR; Ince A; Baraf H; Malamet RL; Teng LL; Kavanaugh A
Ann Rheum Dis; 2012 Feb; 71(2):198-205. PubMed ID: 21949007
[TBL] [Abstract][Full Text] [Related]
6. Laboratory and febrile features after joint surgery in patients with rheumatoid arthritis treated with tocilizumab.
Hirao M; Hashimoto J; Tsuboi H; Nampei A; Nakahara H; Yoshio N; Mima T; Yoshikawa H; Nishimoto N
Ann Rheum Dis; 2009 May; 68(5):654-7. PubMed ID: 18519424
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy and safety of tocilizumab combined with disease-modifying anti-rheumatoid drugs in the treatment of active rheumatoid arthritis: a multi-center, randomized, double-blinded, placebo-controlled trial].
Shi Q; Zhao Y; Bao CD; Li XF; Huang F; Zhu P; Li ZG; Gu JR; Zhang ZY; Zhao DB; Zhao SL; Jiang QD; Tian J; Zhang FC
Zhonghua Nei Ke Za Zhi; 2013 Apr; 52(4):323-9. PubMed ID: 23925361
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of abatacept and tocilizumab in patients with rheumatoid arthritis treated in clinical practice: results from the nationwide Danish DANBIO registry.
Leffers HC; Ostergaard M; Glintborg B; Krogh NS; Foged H; Tarp U; Lorenzen T; Hansen A; Hansen MS; Jacobsen MS; Dreyer L; Hetland ML;
Ann Rheum Dis; 2011 Jul; 70(7):1216-22. PubMed ID: 21551512
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of tocilizumab combined with cyclosporine A in a patient with rheumatoid arthritis and concomitant chronic hepatitis C virus infection.
Giannitti C; Fineschi I; Frediani B; Fioravanti A; Galeazzi M
Clin Exp Rheumatol; 2013; 31(5):816. PubMed ID: 24021246
[No Abstract] [Full Text] [Related]
10. Recurrent allergic bronchopulmonary aspergillosis in a patient with rheumatoid arthritis treated with etanercept and tocilizumab.
Honda H; Kida H; Yoshida M; Tomita T; Fujii M; Ihara S; Goya S; Tachibana I; Kawase I
Mod Rheumatol; 2011 Dec; 21(6):660-4. PubMed ID: 21472474
[TBL] [Abstract][Full Text] [Related]
11. Sarcoidosis induced by tocilizumab: a paradoxical event?
Nutz A; Pernet C; Combe B; Cohen JD
J Rheumatol; 2013 Oct; 40(10):1773-4. PubMed ID: 24085760
[No Abstract] [Full Text] [Related]
12. Toxidermia under treatment with tocilizumab for rheumatoid arthritis.
Fechtenbaum M; Banse C; Boyard-Lasselin P; Goëb V
Joint Bone Spine; 2015 Jan; 82(1):69-70. PubMed ID: 25048098
[No Abstract] [Full Text] [Related]
13. Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis.
Kojima T; Yabe Y; Kaneko A; Hirano Y; Ishikawa H; Hayashi M; Miyake H; Takagi H; Kato T; Terabe K; Wanatabe T; Tsuchiya H; Kida D; Shioura T; Funahashi K; Kato D; Matsubara H; Takahashi N; Hattori Y; Asai N; Ishiguro N
Mod Rheumatol; 2013 Sep; 23(5):977-85. PubMed ID: 23099471
[TBL] [Abstract][Full Text] [Related]
14. Risk of infections in rheumatoid arthritis patients treated with tocilizumab.
Lang VR; Englbrecht M; Rech J; Nüsslein H; Manger K; Schuch F; Tony HP; Fleck M; Manger B; Schett G; Zwerina J
Rheumatology (Oxford); 2012 May; 51(5):852-7. PubMed ID: 21865281
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study).
Ohta S; Tsuru T; Terao K; Mogi S; Suzaki M; Shono E; Ishida Y; Tarumi E; Imai M
J Clin Pharmacol; 2014 Jan; 54(1):109-19. PubMed ID: 24115082
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity reactions to tocilizumab: role of skin tests in diagnosis.
Rocchi V; Puxeddu I; Cataldo G; Del Corso I; Tavoni A; Bazzichi L; Bombardieri S; Migliorini P
Rheumatology (Oxford); 2014 Aug; 53(8):1527-9. PubMed ID: 24899663
[No Abstract] [Full Text] [Related]
17. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study.
Genovese MC; McKay JD; Nasonov EL; Mysler EF; da Silva NA; Alecock E; Woodworth T; Gomez-Reino JJ
Arthritis Rheum; 2008 Oct; 58(10):2968-80. PubMed ID: 18821691
[TBL] [Abstract][Full Text] [Related]
18. Safety of subcutaneous versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
McLaughlin M; Östör A
Expert Opin Drug Saf; 2015 Mar; 14(3):429-37. PubMed ID: 25553607
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacology of tocilizumab for the treatment of patients with rheumatoid arthritis.
Zhang X; Peck R
Expert Rev Clin Pharmacol; 2011 Sep; 4(5):539-58. PubMed ID: 22114882
[TBL] [Abstract][Full Text] [Related]
20. Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis.
Sakaue S; Sumitomo S; Kubo K; Fujio K; Yamamoto K
Rheumatology (Oxford); 2014 Aug; 53(8):1529-30. PubMed ID: 24609062
[No Abstract] [Full Text] [Related]
[Next] [New Search]
